These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9025741)
41. Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging. van Veen SA; Balm AJ; Valdés Olmos RA; Hoefnagel CA; Hilgers FJ; Tan IB; Pameijer FA Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):406-11. PubMed ID: 11296049 [TBL] [Abstract][Full Text] [Related]
42. Clinical application of 201Tl SPECT imaging of brain tumors. Sun D; Liu Q; Liu W; Hu W J Nucl Med; 2000 Jan; 41(1):5-10. PubMed ID: 10647598 [TBL] [Abstract][Full Text] [Related]
43. Radioguided surgery in brain tumors with thallium-201. Serrano J; Rayo JI; Infante JR; Domínguez L; García-Bernardo L; Durán C; Fernández Portales I; Cabezudo JM Clin Nucl Med; 2008 Dec; 33(12):838-40. PubMed ID: 19033782 [TBL] [Abstract][Full Text] [Related]
44. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. Kostakoglu L; Uysal U; Ozyar E; Hayran M; Uzal D; Demirkazïk FB; Kars A; Atahan L; Bekdik CF J Nucl Med; 1997 Jul; 38(7):1009-14. PubMed ID: 9225780 [TBL] [Abstract][Full Text] [Related]
45. Intracranial tumors after radiation therapy: role of 99mTc-tetrofosmin SPECT/CT with a hybrid camera. Filippi L; Santoni R; Nicolì P; Danieli R; Schillaci O Cancer Biother Radiopharm; 2009 Apr; 24(2):229-35. PubMed ID: 19409045 [TBL] [Abstract][Full Text] [Related]
46. The retention indices of 201Tl-SPECT in brain tumors. Otsuka H; Shinbata H; Hieda M; Yamashita K; Kitamura H; Senba T; Kashihara K; Tagashira H Ann Nucl Med; 2002 Nov; 16(7):455-9. PubMed ID: 12508835 [TBL] [Abstract][Full Text] [Related]
47. [Quantitative assessment of the usefulness of MR-fusion Tl-SPECT image in the diagnosis of brain tumor]. Nagai H; Haramoto M; Takada D; Daisu M; Miyazaki T; Sugimoto K; Akiyama Y; Moritake K; Yamamoto Y No Shinkei Geka; 2008 Dec; 36(12):1093-101. PubMed ID: 19086439 [TBL] [Abstract][Full Text] [Related]
48. [Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy]. Suzuki A; Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K No To Shinkei; 1996 May; 48(5):449-57. PubMed ID: 8672304 [TBL] [Abstract][Full Text] [Related]
49. Comparison of differential diagnostic capabilities of 201Tl scintigraphy and fine-needle aspiration of thyroid nodules. Okumura Y; Takeda Y; Sato S; Komatsu M; Nakagawa T; Akaki S; Kuroda M; Joja I; Hiraki Y J Nucl Med; 1999 Dec; 40(12):1971-7. PubMed ID: 10616873 [TBL] [Abstract][Full Text] [Related]
50. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma. Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199 [TBL] [Abstract][Full Text] [Related]
51. Thallium-201 SPECT in the evaluation of early effects on brain tumors treated with stereotactic irradiation. Tomura N; Izumi J; Anbai A; Takahashi S; Sakuma I; Omachi K; Kidani H; Sasaki K; Watarai J; Suzuki A; Mizoi K Clin Nucl Med; 2005 Feb; 30(2):83-6. PubMed ID: 15647671 [TBL] [Abstract][Full Text] [Related]
52. Comparative evaluation of 201Tl SPECT and CT in the follow-up of irradiated brain tumors. Datta NR; Pasricha R; Gambhir S; Prasad SN; Phadke RV Int J Clin Oncol; 2004 Feb; 9(1):51-8. PubMed ID: 15162827 [TBL] [Abstract][Full Text] [Related]
53. 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas. Kallén K; Burtscher IM; Holtås S; Ryding E; Rosén I J Neurooncol; 2000; 46(2):173-85. PubMed ID: 10894370 [TBL] [Abstract][Full Text] [Related]
54. Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E AJNR Am J Neuroradiol; 1996 May; 17(5):925-32. PubMed ID: 8733968 [TBL] [Abstract][Full Text] [Related]
55. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. Buchpiguel CA; Alavi JB; Alavi A; Kenyon LC J Nucl Med; 1995 Jan; 36(1):159-64. PubMed ID: 7799071 [TBL] [Abstract][Full Text] [Related]
56. Dual-isotope SPECT of skull-base invasion of head and neck tumors. Fukumoto M; Yoshida S; Yoshida D; Kishimoto S J Nucl Med; 1995 Oct; 36(10):1741-6. PubMed ID: 7562037 [TBL] [Abstract][Full Text] [Related]
57. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081 [TBL] [Abstract][Full Text] [Related]